AIZ vs MIST · P/E 15, rev $3.45B vs rev $797.0K
Assurant Inc (AIZ) versus Milestone Pharmaceuticals Inc (MIST) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported MIST revenue for 2026-06-30 was $797.0K. Net income was -$54.7M. MIST currently screens at market cap $160.6M.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. MIST currently screens at market cap $160.6M.
Not investment advice. Open the AIZ and MIST stock pages for the full models.
Not investment advice.